期刊文献+

靶向蛋白质-RNA相互作用的HIV抑制剂研究进展

Advances in HIV inhibitors targeting protein-RNA interactions
原文传递
导出
摘要 蛋白质-RNA相互作用是人免疫缺陷病毒(HIV)抑制剂研究的重要靶点,抑制RNA与蛋白质结合是获得具有抗耐药性HIV药物的有效途径。近年来,大量药物的筛选获得了许多蛋白质-RNA相互作用的抑制剂,本文总结了近年来以蛋白质-RNA相互作用为靶点的HIV抑制剂的研究进展。 Protein-RNA interaction is an important target for HIV inhibitors. Inhibiting protein-RNA interaction is an effective way to obtain HIV inhibitors with anti-drug resistance. Recently, a number of drug screening approaches have been used to get HIV inhibitors targeting protein-RNA interactions. This review summarizes the recent progress in this field.
作者 邹今幂 高萍 赵法宝 展鹏 刘新泳 ZOU Jin-mi;GAO Ping;ZHAO Fa-bao;ZHAN Peng;LIU Xin-yong(Department of Medicinal Chemistry,Key Laboratory of Chemical Biology(Ministry of Education),School of Pharmaceutical Sciences,Shandong University,Ji'nan 250012,China)
出处 《中国药物化学杂志》 CAS CSCD 北大核心 2018年第5期400-413,共14页 Chinese Journal of Medicinal Chemistry
基金 2017年山东省重点研发计划项目(2017CXGC1401) 国家自然科学基金重点国际合作研究项目(81420108027)
关键词 人免疫缺陷病毒(HIV-1) 艾滋病 RNA-蛋白质相互作用 药物设计 抑制剂 HIV-1 AIDS protein-RNA interaction drug design inhibitor
  • 相关文献

参考文献1

二级参考文献11

  • 1Baba M. Recent status of HIV-1 gene expression inhibitors [J]. Antivir Res, 2006, 71: 301-306.
  • 2D'Orso I, Grunwell JR, Nakamura RL, et al. Targeting Tat inhibitors in the assembly of human immunodeficiency virus type 1 transcription complexes [J]. J Virol, 2008, 82: 9492- 9504.
  • 3Giacca M. The HIV-1 Tat protein: a multifaceted target for novel therapeutic opportunities [J]. Curr Drug Targets Immune Endocr Metabol Disord, 2004, 4: 277-285.
  • 4Kashanchi F, Sadaie MR, Brady JN. Inhibition of HIV-1 transcription and virus replication using soluble Tat peptide analogs [J]. Virology, 1997, 227: 431-438.
  • 5Agbottah E, Zhang N, Dadgar S, et ai. Inhibition of HIV-1 virus replication using small soluble Tat peptides [J]. Viroiogy, 2006, 345: 373-389.
  • 6Pantano S, Carloni P. Comparative analysis of HIV-1 Tat variants [J]. Proteins, 2005, 58: 638-643.
  • 7Esquieu D, Peloponese JM, Opi S, et al. Discovery of a Tat HIV-1 inhibitor through computer-aided drug design [J]. Spectroscopy, 2003, 17: 639-645.
  • 8Braddock M, Cannon P, Muckenthaler M, et al. Inhibition of human immune-deficiency virus type 1 Tat-dependent activation of translation in Xenopus oocytes by the benzodiazepine Ro24-7429 requires trans-activation response element loop sequences [J]. J Viral, 1994, 68: 25-33.
  • 9Kira T, Hashimoto K, Baba M, et al. 2-Glycineamide- 5-chlorophenyl 2-pyrryl ketone, a non-benzodiazepin Tat antagonist, is effective against acute and chronic HIV-1 infections in vitro [J]. Antiviral Res, 1996, 32: 55-62.
  • 10Chen FE. Synthetic Methods for Organic Drugs: Vol 1.(有机药物合成法:第一卷)[M]. Beijing: China Medical Science Press, 1998: 28-30; 234-236.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部